| Affymax, Takeda announce US FDA acceptance of NDA for peginesatide - pharmabiz.com |
|
|
pharmabiz.com If approved, peginesatide will be the first once-monthly Erythropoiesis Stimulating Agent (ESA) available for the treatment of anaemia associated with CKD patients on dialysis in the United States. Peginesatide is a synthetic, PEGylated peptidic |